NCT06387381View on ClinicalTrials.gov

68Ga-PSFA PET Imaging in Patients With PSMA/FAP Positive Disease

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

May 20, 2024

Primary Completion Date

April 30, 2025

Study Completion Date

December 31, 2026

Conditions
PSMAFAPPositron-Emission Tomography
Interventions
DRUG

68Ga-PSFA

Each subject receives a single intravenous injection of 68Ga-PSFA.

Trial Locations (1)

400016

RECRUITING

The First Affiliated Hospital of Chongqing Medical University, Chongqing

All Listed Sponsors
lead

First Affiliated Hospital of Chongqing Medical University

OTHER